CD14 and hepatocellular carcinoma: Radiotherapy significantly reduced the frequency of CD14+HLA−DR−/low MDSCs that was negatively correlated to patient overall survival, indicating that a reduction of MDSCs after radiotherapy could be used as a prognostic factor in hepatocellular carcinoma patients (156).